| Brand Name | Evycare |
|---|---|
| Industry / Business Category | Healthcare Products |
| Founded Year | 2023 |
| Franchise Started Year | 2023 |
| Total Franchise Outlets | 100–200 |
| Estimated Investment | INR 50 K – 2 Lakh |
| Franchise Fee | Not specified |
| Royalty Fee | Not specified |
| Space Requirement | 100–200 Sq.ft |
| Staff Requirement | Not specified |
| Expected Payback Period | 1–2 Years |
Evycare is an Indian pharmaceutical company operating in the healthcare products sector. The brand provides a wide range of pharmaceutical products across multiple therapeutic categories. It serves retail, wholesale, and institutional markets while offering PCD (Propaganda Cum Distribution) franchise opportunities for entrepreneurs and distributors.
Customers access Evycare products through franchise partners, retail outlets, and institutional distributors. Products are supplied directly to franchisees who manage local sales and distribution. Daily operations include inventory management, order fulfillment, marketing support, and customer engagement. Revenue is generated through the sale of pharmaceutical products and distribution agreements.
| Pharmaceutical Products | Wide portfolio across major therapeutic segments |
|---|---|
| PCD Pharma Franchise Opportunities | Distribution rights for retailers, wholesalers, and entrepreneurs |
| Promotional Materials | Marketing support including visual aids, sample kits, and branded merchandise |
| Customized Business Solutions | Tailored franchise models based on partner requirements |
Franchise partners operate under Evycare’s PCD pharma model with area-specific monopoly rights. Franchise owners are responsible for sales, distribution, and local customer engagement. The franchisor provides product supply, marketing support, promotional materials, and operational guidance. Partners benefit from brand support, timely deliveries, and access to an established product portfolio.
| Estimated Investment | INR 50 K – 2 Lakh |
|---|---|
| Franchise Fee | Not specified |
| Royalty / Ongoing Fees | Not specified |
| Setup Costs | Outlet space, initial inventory, promotional materials |
| Operational Costs | Staff, utilities, local marketing |
The investment covers the establishment of a franchise outlet and early operational expenses.
| Space Requirement | 100–200 Sq.ft |
|---|---|
| Preferred Locations | Retail areas accessible to pharmacies, healthcare providers, and urban customers |
| Equipment Needs | Storage units, product display areas, basic office infrastructure |
| Staffing Requirements | Dependent on outlet size and sales volume |
Franchise revenue is generated from product sales and distribution to retailers and customers. Pricing is based on product categories and sales volume. Repeat orders, demand across multiple therapeutic segments, and area-specific monopoly rights contribute to revenue stability. Expected payback period ranges from 1–2 years, depending on market adoption and operational efficiency.
| Established Year | 2023 |
|---|---|
| Franchise Commencement | 2023 |
| Number of Franchise Outlets | 100–200 |
| Geographic Markets Served | Across multiple states in India |
| Expansion Plans | Rapid expansion inviting partners from every district and region of India |
The investment ranges from INR 50 K – 2 Lakh, covering outlet setup, inventory, and initial operational costs.
Franchisees operate under the PCD pharma model with area-specific distribution rights, handling local sales and customer engagement with brand support.
Outlets require 100–200 Sq.ft for product storage, display, and basic operations, suitable for retail or distribution locations.
The expected payback period is 1–2 years, depending on sales performance and market demand.
Prospective partners can contact Evycare to inquire about area availability, investment details, and onboarding procedures. ## 13. Similar Franchise Opportunities
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.